Pharma giant’s share price has fallen below pre-pandemic levels after shortlived bump from Covid vaccine
US biotech researches treatments to reduce muscle loss from blockbuster diet medicines
Weight loss drugs appear to be having an effect at the population level
Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure Act
The company is thriving as weight-loss drugs boom, but investors see warning signs it has reached ‘peak enthusiasm’
Weight-loss drugs and a new focus on wellness are pushing many exercise machines towards obsolescence
Artificial intelligence used to help researchers plan experiments and better predict outcomes
Drugmaker’s CEO sees chance to widen use of anti-obesity medications for ‘health maintenance’
Interest of PE groups in Sanofi’s Opella highlights the renewed ebullience of debt financiers
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
The reduced effectiveness of antibiotics risks severe disruption to the global economy
Joe Kiani asserts in a California lawsuit that he is entitled to severance under provisions typically tied to a company sale
The lessons learnt from drug-resistant tuberculosis offer a path to beating back the ‘silent pandemic’ of antimicrobial resistance
Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product
Latest setback for Dato-DXd comes after disappointing results in lung cancer treatment earlier this month
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ Americans
Gavi chief Sania Nishtar offers rich nations long-term payment options for life-saving jabs
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high
But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness
Philip Morris pivot from tobacco to healthcare with purchase of Vectura sparked opposition from doctors
Results offer hope of progress in combating bladder tumours and some forms of breast cancer
High rates of vomiting among those who took strong doses in trials have unsettled investors
Contact lens supplier is looking for buyers to separate from indebted parent company
Company’s chief oncology officer says reforms risk discouraging treatments for paediatric and rare conditions
GSK and AstraZeneca plan final trials to upgrade propellants that cause much of the sector’s carbon footprint
